Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Net Cash Flow (2016 - 2025)

Medifast (MED) has disclosed Net Cash Flow for 16 consecutive years, with -$10.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 58.05% year-over-year to -$10.2 million, compared with a TTM value of -$1.6 million through Dec 2025, up 54.23%, and an annual FY2025 reading of -$1.6 million, up 54.23% over the prior year.
  • Net Cash Flow was -$10.2 million for Q4 2025 at Medifast, down from -$2.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $42.2 million in Q1 2021 and bottomed at -$57.1 million in Q2 2022.
  • Average Net Cash Flow over 5 years is -$3.7 million, with a median of $1.9 million recorded in 2024.
  • Peak annual rise in Net Cash Flow hit 208.25% in 2021, while the deepest fall reached 793.52% in 2021.
  • Year by year, Net Cash Flow stood at -$50.3 million in 2021, then soared by 136.46% to $18.3 million in 2022, then plummeted by 198.75% to -$18.1 million in 2023, then plummeted by 34.59% to -$24.4 million in 2024, then surged by 58.05% to -$10.2 million in 2025.
  • Business Quant data shows Net Cash Flow for MED at -$10.2 million in Q4 2025, -$2.2 million in Q3 2025, and $10.0 million in Q2 2025.